Operating results

INTCO Medical’s annual performance was solid, with revenue reaching 6.919billion yuan, net profit attributable to the parent company of 383million yuan, net operating cash flow of 502million yuan, net assets attributable to the parent company of 16.029 billion yuan, and total assets of 27.079 billion yuan.

Develop new markets

In 2023, INTCO Medical participated in a total of 40 worldwide exhibitions, leaving footprints in nearly 20 countries and regions including China, the United States, Germany, Turkey, Japan, South Korea, Saudi Arabia, and the United Arab Emirates.

Enhance brand awareness

Continue to enhance INTCO Medical’s global brand awareness and market share. In 2023, our company built the global business card of INTCO Medical based on domestic platforms such as Douyin, WeChat, Weibo, and Xiaohongshu, as well as overseas platforms such as Google, LinkedIn, Youtube, and Facebook, to deeply reach users.

Leading the development of the industry

As the world’s leading manufacturer of disposable gloves, INTCO Medical’s annual production capacity of disposable gloves exceeded 79billion pieces in 2023.

In March 2023, INTCO Medical, jointly with the China Finance Media and LeadLeo, released the “White Paper on the Development of China’s Disposable Nitrile Gloves Industry in 2023”, giving full play to its role as an industry leader and contributing to the realization of the vision of “Healthy China 2030” strength.

Maintain new product research and development

In 2023, the number of new INTCO Medical products on the market increased by 78% year-on-year. The three major business divisions of medical consumables, rehabilitation equipment, and physiotherapy care continued to launch new products and deepened product segmentation and peripheral product development in different application scenarios and application industries.

New product recommendations: Diamond Textured Nitrile Gloves, Disposable Cleanroom Nitrile Gloves, Synguard G3 Nitrile Gloves.

Talent development

INTCO Medical has more than 10,000 employees worldwide. Over the years, our company has adhered to a people-oriented approach and is committed to working with its employee to move forward and grow together. In 2023, our company strengthened and carried out three-level training, and conducted comprehensive training for all employees from the dimensions of leadership, professional skills, and general knowledge literacy.

In the summer of 2023, INTCO Medical organized employees and their families to embark on a trip to Thailand. Provide their employees with opportunities to see the world, so that everyone can better understand and integrate into different cultures, and convey friendliness and care.

Sustainable development

In 2023, INTCO Medical has gained a lot in the field of ESG. Behind the repeated ESG awards is our company’s persistence in integrating ESG concepts into corporate operations and development.

In 2023, the “INTCO Medical·Midwest 100 Plan” public welfare activity was officially launched. In the post-epidemic era, it helps improve the medical protection conditions of county-level hospitals in the central and western regions and provides comprehensive guarantees for optimizing the medical treatment environment.

In addition to the medical industry, INTCO Medical focuses on various public welfare activities and demonstrates its sense of responsibility and corporate responsibility in multiple public welfare and charity fields.